Skip to content

What is the new injection for 75-79 year olds?: The latest recommendations explained

5 min read

According to the Centers for Disease Control and Prevention (CDC), all adults aged 75 years and older are now recommended to receive a single dose of an RSV vaccine to help prevent severe illness. This updated guideline addresses the question of what is the new injection for 75-79 year olds and highlights the importance of protecting against common respiratory viruses. New recommendations also include a second dose of the updated COVID-19 vaccine for this age group.

Quick Summary

Adults aged 75–79 should receive a one-time RSV vaccine and a second dose of the updated 2024–2025 COVID-19 vaccine. Other key vaccinations, like shingles and pneumococcal shots, remain important for this age group to prevent severe diseases and their complications.

Key Points

  • New RSV Vaccine Recommendation: The CDC now recommends a single dose of an RSV vaccine for all adults 75 and older to prevent severe lower respiratory illness.

  • Updated COVID-19 Shot: Adults aged 65 and older are advised to get a second dose of the 2024–2025 COVID-19 vaccine six months after their first dose to boost protection.

  • Continued Need for Shingrix: The two-dose Shingrix vaccine remains the standard recommendation for preventing shingles and long-term nerve pain in adults 50 and older.

  • Revised Pneumococcal Guideline: The age for routine pneumococcal vaccination was lowered to 50 and up, making it crucial for 75-79 year olds to ensure they are up-to-date.

  • Seasonal Flu Shot: High-dose or adjuvanted flu shots are recommended annually for adults 65 and over to provide a stronger immune response.

  • Benefits Outweigh Risks: The benefits of these vaccinations in preventing severe illness, hospitalization, and complications significantly outweigh the common, temporary side effects.

In This Article

What is the new injection for 75-79 year olds?

For 75-79 year olds, a significant and new recommendation is the respiratory syncytial virus (RSV) vaccine. This recommendation was updated in 2024 to specifically include all adults 75 and older, reflecting the recognition of how serious RSV can be for this age group. The CDC now recommends that all adults 75 years and older receive a single dose of an FDA-licensed RSV vaccine. There are currently three FDA-approved RSV vaccines available: GSK's Arexvy, Moderna's mResvia, and Pfizer's Abrysvo. These are not annual injections like the flu shot, and most eligible adults will only need a single dose.

Additionally, there is an updated COVID-19 vaccine recommended for this age group. In October 2024, the CDC recommended a second dose of the 2024–2025 COVID-19 vaccine for individuals aged 65 and older. This is due to waning immunity over time and the continued circulation of the virus. These key updates address the most recent public health guidance for older adults.

Comparing key vaccines for older adults

Older adults should remain current on several other key vaccinations besides the new RSV and updated COVID-19 injections. These vaccines protect against serious illnesses and their potential complications. The following table provides a comparison of these vital vaccines.

Vaccine Target Disease Target Age Group Dosing Potential Side Effects
RSV Vaccine (Arexvy, Abrysvo, mResvia) Respiratory Syncytial Virus (RSV) All adults 75+ (and 50-74 with risk factors) Single dose Pain, redness, swelling at injection site; fatigue, headache
COVID-19 Vaccine (2024-2025 formula) SARS-CoV-2 (COVID-19) All adults 65+ Two doses for 65+, 6 months apart Injection site pain, fatigue, headache, muscle aches, fever
Shingrix (Shingles Vaccine) Shingles and Postherpetic Neuralgia (PHN) Healthy adults 50+ Two doses, 2–6 months apart Injection site pain, muscle aches, fatigue, headache, shivering, fever
Pneumococcal Vaccines (PCV15, PCV20, PCV21) Pneumococcal Disease (including pneumonia) All adults 50+ (and younger adults with risk factors) Dosing depends on vaccine type and history Pain, redness, swelling at injection site; fever, muscle aches
Flu Vaccine (High-Dose/Adjuvanted) Influenza (Flu) Adults 65+ Annual, single dose (in late summer/fall) Soreness, swelling, redness at injection site; headache, muscle aches

How these injections benefit older adults

For adults in the 75-79 age range, these injections provide crucial protection as their immune systems may be less robust than younger individuals. Age-related changes make older adults more susceptible to severe complications from respiratory infections and other diseases. Here's how these specific vaccines help:

  • RSV Vaccine: This is particularly important because RSV can cause severe lower respiratory tract infections, leading to hospitalization and even death in older adults. The recent recommendation for all individuals 75 and older acknowledges their increased risk. The vaccine provides robust protection against this serious illness.
  • Updated COVID-19 Vaccine: Given that COVID-19 remains a threat, especially for older Americans, the second dose recommended for 65+ in the 2024-2025 season helps ensure continued high-level immunity. This is especially crucial as vaccine effectiveness can wane over time.
  • Shingrix (Shingles) Vaccine: Shingles can be extremely painful and lead to long-term nerve pain (postherpetic neuralgia), which is more common and severe in older adults. The Shingrix vaccine is over 90% effective at preventing shingles and its complications in adults aged 50 and older.
  • Pneumococcal Vaccines: Pneumococcal disease, which can cause pneumonia, meningitis, and bloodstream infections, is a serious threat to older adults. The CDC's recent lowering of the recommended age to 50 ensures earlier and broader protection for those at risk.
  • High-Dose Flu Vaccine: Adults 65 and older are recommended to receive a high-dose or adjuvanted flu vaccine, which provides a stronger immune response and better protection against influenza.

Are there any risks or side effects?

As with any medication, injections carry potential side effects, which are generally mild and temporary. For the new RSV vaccines, common side effects can include soreness or redness at the injection site, fatigue, and headache. The updated COVID-19 vaccines may cause similar symptoms, such as fever or muscle aches. Shingrix is associated with more noticeable side effects like fatigue and shivering, especially after the second dose. However, these are typically short-lived and pale in comparison to the potential severity of the diseases they prevent. It is important for individuals to discuss any concerns with a healthcare provider, especially if they have underlying health conditions or have experienced severe allergic reactions to vaccines in the past.

Conclusion

For adults aged 75 to 79, the most significant new injection is the Respiratory Syncytial Virus (RSV) vaccine, now a routine recommendation to prevent severe lower respiratory illness. Alongside this, a second dose of the updated 2024–2025 COVID-19 vaccine is also recommended to maintain immunity. These join other standard vaccinations like the high-dose flu vaccine, Shingrix for shingles, and pneumococcal vaccines as essential components of preventive care for seniors. By staying informed and up-to-date with these key injections, older adults can significantly reduce their risk of serious and life-threatening infections. Always consult a healthcare professional to determine the most appropriate vaccination schedule for your individual health needs. The CDC and other health authorities provide comprehensive, evidence-based guidance to help navigate these important health decisions.

Why it’s important to prioritize vaccinations for older adults

For the 75-79 age bracket, a compromised or weaker immune system is a major concern. The body's ability to fight off infections naturally declines with age, making common viruses like RSV and flu more dangerous. Vaccinations train the immune system to recognize and fight pathogens, creating a protective barrier against severe illness, hospitalization, and death. For example, the CDC highlights that older adults are at increased risk for severe disease from RSV, including pneumonia. Ensuring vaccinations are up-to-date is a simple yet powerful strategy to maintain health and quality of life. The benefits of vaccination—preventing devastating illness and its complications—are far greater than the minor, temporary side effects.

Visit the CDC's website for the full immunization schedules for adults.

How to get vaccinated

Vaccinations for older adults are widely available through several channels. A doctor's office or clinic is the most common option, where a healthcare provider can review your history and recommend the right vaccines. Additionally, most pharmacies, including those in large grocery and drug store chains, offer a variety of adult vaccinations, including RSV, flu, shingles, and COVID-19 shots. For those with mobility issues, some health services offer in-home vaccination programs. Before visiting, it is always a good practice to call ahead to ensure the desired vaccine is in stock. You should also check with your insurance provider, as most recommended adult vaccines, including RSV, shingles (Shingrix), and COVID-19 shots, are covered by Medicare and most private insurance plans. For those without insurance, several public health programs can assist with costs.

Frequently Asked Questions

For adults aged 75-79, the latest recommendations include a one-time RSV vaccine and a second dose of the 2024-2025 COVID-19 vaccine, in addition to standard vaccinations like the shingles (Shingrix), pneumococcal, and annual high-dose flu shots.

Yes, the RSV vaccine is a newer immunization for older adults. The CDC recommended in 2024 that all adults 75 years and older receive a single dose to protect against severe respiratory syncytial virus (RSV) infection.

Yes, the CDC recommends that adults 65 and older receive a second dose of the updated 2024–2025 COVID-19 vaccine, spaced six months after their last dose, to maintain protection against circulating variants.

In late 2024, the CDC lowered the routine pneumococcal vaccination age from 65 to 50 for all adults, making it an essential vaccination for the 75-79 age group.

The RSV vaccine is not an annual shot. The CDC recommends a single dose for eligible adults aged 75 and older, with no need for an additional dose at this time.

Yes, Medicare typically covers the recommended vaccinations for older adults, including the RSV, shingles (Shingrix), and COVID-19 vaccines. The Inflation Reduction Act eliminated cost-sharing for many adult vaccines recommended by the Advisory Committee on Immunization Practices.

Yes, the CDC states that RSV vaccines can often be co-administered with other adult vaccines during the same visit. However, it's best to discuss this with your healthcare provider to consider any potential side effects.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.